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Conclusions
There is some evidence for the effectiveness of 
mbsr in improving psychological health in breast 
cancer patients, but more rcts are needed to un-
derpin those results.
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1. INTRODUCTION
Breast cancer is the second most common cancer 
worldwide despite the fact that it is rare in men. In 
2008, about 1.5 million new cases were diagnosed. Of 
all female cancers in 2008, 23% were breast cancers1. 
Although breast cancer mortality is still the highest 
among all cancers in women1, survival rates are in-
creasing2. However, cancer diagnosis and treatment 
are often associated with physical and psychosocial 
impairments. Pain, fatigue, depression, and anxiety 
are the most common complaints in cancer patients3. 
Almost half of all cancer patients report fatigue as 
a problem, and more than one third experience sub-
stantial psychological distress4,5.
Complementary and alternative medicine is 
widely used by breast cancer patients to cope with 
symptoms of their disease6. More than 30% of all 
cancer patients utilize complementary medicine7.
Several complementary cancer treatments are 
based on mindfulness. Derived from the Buddhist 
Theravada tradition8, mindfulness has been viewed 
as the core construct of Buddhist meditation9. The 
mindfulness construct therefore describes engage-
ment in a special form of meditation, but also a 
state of consciousness that has been characterized 
as a nonjudgmental moment-to-moment awareness 
and a curious experiential openness and acceptance 
towards one’s own experiences10. Mindfulness-based 
ABSTRACT
Objective
The aim of this systematic review and meta-analysis 
was to assess the effectiveness of mindfulness-based 
stress reduction (mbsr) and mindfulness-based cog-
nitive therapy (mbct) in patients with breast cancer.
Methods
The medline, Cochrane Library, embase, cambase, and 
PsycInfo databases were screened through Novem-
ber 2011. The search strategy combined keywords 
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interventions therefore include not only training in 
the formal practice of mindfulness (mediation or 
mindful exercises, or both), but also training in the 
informal practice of mindfulness (retaining a mind-
ful state of consciousness during routine activities 
in everyday life)9,11.
The most commonly used mindfulness-based 
interventions are mindfulness-based stress reduc-
tion (mbsr) and mindfulness-based cognitive therapy 
(mbct)12,13. Mindfulness-based stress reduction is 
a structured 8-week group program of weekly 
2.5-hour sessions and 1 all-day silent retreat. Key 
components of the program are sitting meditation, 
walking meditation, hatha yoga, and body scan (a 
sustained mindfulness practice in which attention is 
sequentially focused on various parts of the body)9. 
Another important component is the transition of 
mindfulness into everyday life. Mindfulness-based 
cognitive therapy combines mbsr with cognitive–
behavioral techniques14,15. Originally developed as 
a treatment for major depression14, mbct is more and 
more adapted for other specific conditions15. Other 
mindfulness-based interventions include mindful 
exercise16 and mindfulness-based art therapy17. A 
number of systematic reviews and meta-analyses 
suggest that mindfulness-based interventions are 
effective in chronic pain18, anxiety, and depres-
sion19. The effectiveness of mindfulness-based 
interventions in cancer treatment has also been 
systematically reviewed20–22. Mindfulness-based 
stress reduction seems to be especially effective for 
a variety of psychosocial cancer symptoms such as 
stress, depression, anxiety, and reduced quality of 
life20–22; its effect on physical symptoms seems to be 
small20. The only systematic review of mbsr specifi-
cally for patients with breast cancer so far suggests 
a large effect of mbsr on psychological symptoms, 
mainly stress and anxiety, but a meta-analysis was 
not performed23.
The aim of the present review was to systemati-
cally assess and meta-analyze the effectiveness of 
mbsr and mbct in patients with breast cancer.
2. METHODS
The prisma (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) guidelines were fol-
lowed to conduct this systematic review.
2.1 Literature Search
The medline, embase, Cochrane Library, Psycinfo, 
and cambase databases were searched from their 
inception until November 2011. No language restric-
tions were applied. The literature search consisted 
of key words for mbsr and mbct and keywords for 
breast cancer. The search strategy was adapted for 
each database as necessary. The complete search 
strategy for medline was: (MBSR[Title/Abstract] 
OR MBCT[Title/Abstract] OR mindful*[Title/Ab-
stract]) AND (breast neoplasms[MeSH Terms] OR 
(breast[Title/Abstract] AND (neoplasm*[Title/Ab-
stract] OR cancer[Title/Abstract] OR oncology[Title/
Abstract]))). Reference lists of identified original 
and review papers were hand-searched to locate 
additional papers.
2.2 Eligibility Criteria
Randomized controlled trials (rcts) comparing mbsr 
or mbct with no treatment, usual care, or any active 
treatment were included. Nonrandomized trials were 
excluded. Only studies that assessed mbsr or mbct as 
the main intervention were eligible for inclusion. 
Studies of mindfulness-based interventions that 
were clearly different from the original mbsr or mbct 
programs, such as mindfulness-based exercise or 
art therapy were excluded, but variations of the mbsr 
or mbct programs, such as those of program length, 
frequency, or duration did not hinder inclusion. Stud-
ies that included patients with a diagnosis of breast 
cancer regardless of current treatment status were 
selected, but studies that included heterogeneous 
cancer populations were excluded.
2.3 Data Extraction
Two reviewers extracted data on the characteristics of 
the study (for example, trial design, randomization, 
blinding), characteristics of the patient population 
(sample size, stage of cancer, current treatment, age, 
and so on), characteristics of the intervention and 
control condition (type, program length, frequency, 
and duration, among others), outcome measures, 
results, and safety.
Risk of bias was assessed by two authors inde-
pendently using the Cochrane risk-of-bias tool24.
2.4 Data Analysis
Primary outcome measures were health-related 
quality of life and psychological health. Safety was 
defined as secondary outcome measure. Other out-
come measures in the included studies underwent 
an exploratory analysis. If at least two studies with 
a specific outcome were available, a meta-analysis 
for that outcome was conducted using the Review 
Manager software application (version 5.1: The 
Nordic Cochrane Centre, Copenhagen, Denmark). 
Separate meta-analyses were conducted for measure-
ments made at post-treatment and longest available 
follow-up. A random effects model was used.
Standardized mean differences (smds) with 95% 
confidence intervals (cis) were calculated. The smds 
were calculated as the difference in means between 
groups, divided by the pooled standard deviation. 
Where no standard deviations were available from 
the original records, they were calculated from 
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standard errors, confidence intervals, or t-values, 
when available24.
This effect size is also known in the social sci-
ences as the Hedges (adjusted) g. Cohen’s categories 
were used to evaluate the magnitude of the overall 
effect size with small, moderate, and large effect 
sizes being defined as smd = 0.2 to 0.5, smd = 0.5 to 
0.8, and smd > 0.8 respectively25.
2.5 Assessment of Heterogeneity
Heterogeneity was explored using the I 2 and chi-
square statistics, measures of how much variance 
between studies can be attributed to differences 
between those studies rather than to chance. Mod-
erate, substantial, and considerable heterogeneity 
were indicated by I 2 > 30%, I 2 > 50% and I 2 > 75% 
respectively24. A p value of 0.10 or less from the 
chi-square test was considered to indicate significant 
heterogeneity24. To explore possible reasons for het-
erogeneity, sensitivity analyses were planned by type 
of intervention (mbsr or mbct), type of control treat-
ment (usual care or active comparator), and current 
cancer treatment (use of chemotherapy or radiation, 
or no conventional treatment).
2.6 Publication Bias
Publication bias was assessed by visual analysis of 
funnel plots generated using the Review Manager 
software application. Asymmetry of funnel plots was 
regarded to indicate publication bias26.
3. RESULTS
3.1 Study Selection
The literature search located 118 records, 40 of 
which were duplicates (Figure 1). Seven full-text 
articles were assessed for eligibility. One article had 
to be excluded because the study it reported was not 
randomized27. The remaining six articles reported 
results from three rcts. Two articles28,29 reported 
separate outcomes for one rct, and 3 articles30–32 
reported separate outcomes for another rct. The third 
article33 described part of a larger rct; however, no 
other records for that study could be located.
3.2 Study Characteristics
Table i shows key characteristics of the included 
studies.
All three included rcts were conducted in the 
United States. Patients were recruited from cancer 
centres30–32, hospitals28,29, or private oncology 
practices33. Cancer populations were quite homoge-
neous between the studies, with no study including 
patients with metastatic breast cancer. Patients in 
two studies had recently completed breast cancer 
treatment30–33; patients in the third study were 
included regardless of current cancer treatment 
provided they had been diagnosed within the pre-
ceding 2 years28,29. In the latter study, 11.7% of 
patients received chemotherapy and 24.5% received 
radiation during the study28,29. All three studies 
defined a broad range of ages as eligible for inclu-
sion, but the mean age of the included patients was 
comparable between studies, ranging from 50 years 
to 57.5 years.
3.2.1 MBSR
All included rcts assessed mbsr interventions that 
were adapted from the original mbsr program.
Patients in one trial29 participated in a standard 
mbsr intervention, including eight 2.5- to 3.5-hour 
weekly sessions and an all-day silent retreat. Besides 
the study patients, a heterogeneous group with vari-
ous somatic or psychiatric disorders participated in 
that program. For study participants, the standard 
mbsr program was complemented by preceding and 
ensuing sessions.
The other two rcts30–33 used study-participant-
only programs that differed from the original mbsr 
program mainly in terms of program length. Both 
interventions were only 6 weeks in length, with 
weekly 2-hour sessions. One trial included an all-
day silent retreat33; the other did not30–32. The mbsr 
interventions included formal (sitting meditation, 
walking meditation, body scan, gentle yoga) and 
informal practice of mindfulness. In two trials, the 
program components were adapted to the needs 
and possibilities of breast cancer patients30–33. In 
figure 1 Flowchart of the results of the literature search.
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one trial, the intervention was presented by spe-
cially trained mental health clinicians who were 
long-term meditation practitioners29; in another 
trial, it was presented by a clinical psychologist 
trained and licensed in mbsr30–32. The third trial 
did not report the professional qualification of the 
mbsr instructors33.
3.2.2 Control Conditions
One rct compared mbsr with usual care. The usual-
care group did not receive a specific intervention, 
but did continue standard individual post-treatment 
clinic visits. Patients were instructed not to use mbsr, 
yoga, or meditation during the study period30–32. 
Another rct compared mbsr with usual care and 
a nutrition education program. The nutrition pro-
gram involved education on dietary change and 
group cooking, based on social cognitive theory 
and patient-centered counselling28,29. The third rct 
compared mbsr with free choice stress management. 
Each week, patients were free to choose a stress-
management technique in which to engage—such 
as talking to a friend, exercise, or taking a bath33.
In only one rct were contact time and homework 
practice matched for mbsr and at least one control 
condition29.
3.3 Risk of Bias
Table ii shows risk of bias for each study. No study 
reported methods of random sequence generation 
or allocation concealment. Only one study ad-
dressed blinding, and it reported blinding of pa-
tients and outcome assessors at baseline but not at 
post-treatment assessment30. Selective reporting 
was present in all the included studies: two rcts 
reported results for various outcome measures in 
multiple publications28–32; the third did not report 
results for all pre-specified outcomes33. The overall 
evidence was therefore of unclear selection bias, 
performance bias, and detection bias, with a high 
risk of reporting bias, but a low risk of attrition bias 
and other bias24 (Table ii).
3.4 Outcomes
3.4.1 MBSR Versus Usual Care
Two rcts compared mbsr with usual care28–32, one of 
which included repeated measurements at various 
points in time.
Post-Treatment: Both trials assessed health-re-
lated quality of life post treatment; however, only 
one trial reported significant group differences 
favoring mbsr30. Insufficient reporting of raw data29 
hindered meta-analysis. Both trials also assessed 
a wide range of psychosocial variables post treat-
ment. One trial29 reported mbsr as being superior 
to usual care in improving coping strategies, dis-
tress, resilience, and emotional control (Table i). 
The other trial30 reported significant group differ-
ences favouring mbsr with respect to fear of cancer 
recurrence (Table i).
Both rcts assessed depressive symptoms. One 
trial reported mbsr as being superior to usual care 
in relieving depression30; the other trial reported 
significant group differences for only one of two 
outcome measures for depression29. Meta-analysis 
revealed a small but significant overall effect (smd: 
–0.37; 95% ci: –0.65 to –0.08; p = 0.01). The rcts were 
homogeneous, with an I 2 of 0% (Figure 2).
Both rcts also assessed anxiety. Again, one trial 
found mbsr superior to usual care30, and the other 
trial found mbsr to be superior in only one of two 
outcome measures for anxiety29. The pooled effect 
was significant and of moderate size (smd: –0.51; 95% 
ci: –0.80 to –0.21; p = 0.0009). Again, the rcts were 
homogeneous, with an I 2 of 0% (Figure 2).
table ii Risk of bias assessmenta of the included studies

















(“selection”) (“selection”) (“performance”) (“detection”) (“attrition”) (“reporting”)
Hendersen et al., 201128, Unclear Unclear Unclear Unclear Low risk High risk Low risk
Hébert et al., 200129
Lengacher et al., 200930, Unclear Unclear High risk High risk Low risk High risk Low risk
Lengacher et al., 201131,
Lengacher et al., 201132
Shapiro et al., 200333 Unclear Unclear Unclear Unclear Low risk High risk Low risk
a Using the Cochrane risk of bias tool.
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Both rcts measured spirituality, and one reported 
significant group differences favouring mbsr29. Meta-
analysis did not find significant group differences 
(smd: 0.27; 95% ci: –0.37 to 0.91; p = 0.41; I 2 = 79%).
One rct assessed body mass index and dietary 
intake post treatment, but did not find significant 
differences between mbsr and usual care28. The 
other rct measured immune parameters32. For most 
parameters, the groups were not significantly dif-
ferent, but the percentage of activated T cells and 
the T-helper 1–to–T-helper 2 ratio were significantly 
higher in the mbsr group.
Longest Follow-Up: One rct assessed quality of life 
and psychosocial variables at various points in time, 
with 24 months after the start of the intervention be-
ing the longest follow-up29. At that time point, mbsr 
was superior to usual care in improving anxiety and 
emotional control. The same rct also assessed body 
mass index and dietary intake 12 months after the 
start of the intervention, but did not find significant 
group differences28.
3.4.2 MBSR Versus Nutrition Education Program
One rct compared mbsr with a nutrition education 
program28,29. At the post-treatment assessment, mbsr 
was superior to nutrition education in increasing 
spirituality, resilience, and emotional control, and 
in decreasing distress29. In contrast, nutrition educa-
tion was superior to mbsr in decreasing body mass 
index and dietary intake of total fat and fiber post 
treatment28. At longest follow-up, the only signifi-
cant group difference was total fat intake favouring 
nutrition education28.
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3.4.3 MBSR Versus Free Choice Stress Management
One rct compared mbsr with a free choice of stress 
management technique33. This trial assessed a va-
riety of psychosocial variables post treatment, but 
results for the selected outcome measures have not 
been reported. Results for sleep quality and sleep 
efficiency were reported, but the trial did not find 
any significant group differences.
3.5 Sensitivity Analysis
Because only two studies were included in each 
meta-analysis, sensitivity analyses were impossible.
3.6 Publication Bias
Because of the small number of eligible studies, visual 
analysis of funnel plots led to inconclusive results.
3.7 Safety
No study formally reported the occurrence (or ab-
sence) of adverse events. Only one trial described 
reasons for all drop-outs30. In that trial, only 1 
patient dropped out from the mbsr group, and her 
drop-out was related to recurrence of her cancer30. 
Another trial reported 1 drop-out in the mbsr group 
because of cancer recurrence before the interven-
tion began33, but reasons for drop-outs during the 
intervention period were not given. The third trial 
reported the number of drop-outs, but no reasons 
for the drop-outs28,29.
4. DISCUSSION
Previous systematic reviews found favourable ef-
fects of mbsr on psychosocial variables in cancer 
patients20–22. However, only one systematic review 
so far has focused solely on breast cancer patients23. 
An important finding of previous reviews is that, 
although a considerable amount of literature has been 
published on mbsr in supportive cancer treatment, 
very few rigorous trials have been conducted. That 
finding is confirmed by the results of the present 
systematic review. Literature search identified only 
three rcts, none of them ensuring or reporting rigor-
ous methodology.
Yet, despite the low number of eligible studies, 
meta-analysis found small effects for mbsr compared 
with usual care in decreasing depression and anxi-
ety. Moreover, there is limited evidence from one 
rct each that mbsr can improve coping strategies, 
distress, resilience, emotional control, and fear of 
cancer recurrence. That finding accords with earlier 
meta-analyses on mbsr for heterogeneous cancer 
populations that reported small effect sizes for men-
tal health20 and mood, and moderate effect sizes for 
distress21. However, a recent systematic review23 
reported large effect sizes for mbsr in improving 
anxiety and perceived stress in breast cancer patients, 
but only for uncontrolled trials34–36.
Although the meta-analysis reported here did 
not find a significant effect of mbsr compared with 
usual care for improving spirituality, one trial 
found increased spiritual well-being after mbsr was 
compared with usual care and nutrition education29. 
That finding accords with results from another study 
that found increased spiritual well-being in cancer 
patients after mbsr37.
On the other hand, evidence for physical improve-
ments was very low, which is again consistent with 
earlier meta-analyses in mixed cancer populations, 
which either did not address physical outcomes21 or 
found mostly small effects20,23.
No study reported adverse events, and reasons for 
drop-outs were poorly reported. Those findings are 
unsatisfying, because safety is a major focus in the 
evaluation of therapies. Further trials should focus 
on complete reporting of safety data.
The included studies were conducted in primary, 
secondary, and tertiary care settings. The results of 
the present review are therefore applicable to patients 
in all settings of care, but are, however, limited to 
patients with non-metastatic breast cancer.
All included rcts used mbsr as an intervention. 
No rct assessing the effectiveness of mbct in breast 
cancer patients could be located. Mindfulness-
based cognitive therapy was originally developed 
for patients with recurrent depression14, but is now 
also used in oncology settings38. A rct with mixed 
cancer patients reported significant improvements in 
depression, anxiety, and distress after mbct38. Further 
rcts are needed before the evidence of mbct in breast 
cancer patients can be judged.
For investigating the effectiveness of mbsr, rcts 
are the most suitable design. On the other hand, the 
existential changes that may result from participa-
tion in a mbsr program might be better addressed 
using qualitative approaches39. Additional qualitative 
studies on mbsr that complement rcts in breast cancer 
patients are needed22.
The evidence reviewed here is clearly limited for 
several reasons. First, the total number of eligible rcts 
was small. Only two trials could therefore be included 
in each meta-analysis. Although meta-analyses can be 
done by combining at least two studies24, the conclu-
sions drawn from such meta-analyses remain prelimi-
nary. Second, reporting of the studies themselves was 
incomplete. Risk of selection bias, performance bias, 
and detection bias could therefore not be ruled out. The 
evidence as published raised suspicion of high report-
ing bias. Risk of publication bias could not be ruled out 
because of the small number of included studies. Third, 
meta-analyses could be performed only to compare 
mbsr with usual care. Although the evidence that mbsr 
is superior to usual care is promising, more research is 
needed to evaluate the superiority or inferiority of mbsr 
in comparison with other active treatments.
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5. CONCLUSIONS
This systematic review found some evidence for 
the effectiveness of mbsr in improving psycho-
logical health in breast cancer patients, although the 
evidence was limited by incomplete reporting and 
shortcomings in the methodology of the included tri-
als. The existing data are promising, but further and 
more rigorous research is needed before the evidence 
for mbsr in supportive breast cancer treatment can be 
conclusively judged.
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